De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools
OR, United StatesRebecca Michael, PhD; Senior Group Leader, Cell and Molecular Biology Group There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification […]